ArticleInternational journal of molecular sciences2023

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Ameliorate Metabolic Disorder and Obesity Induced Cardiomyocyte Injury and Mitochondrial Remodeling.

Shih-Jie Jhuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.